MetaADEDB 2.0 @ LMMD
Chlorprothixene
(WSPOMRSOLSGNFJ-AUWJEWJLSA-N)
Structure
SMILES
CN(CC/C=C\1/c2ccccc2Sc2c1cc(Cl)cc2)C
Type(s)
Approved; Experimental; Investigational; Withdrawn
ATC code(s)
N05AF03
Molecular Formula:
C18H18ClNS
Molecular Weight:
315.860
Log P:
5.1880
Hydrogen Bond Acceptor:
2
Hydrogen Bond Donor:
0
TPSA:
28.54
CAS Number(s):
113-59-7
Synonym(s)
1.
Chlorprothixene
2.
Chlorprotixen
3.
Taractan
External Link(s)
MeSHD002749
PubChem Compound667467
667466
BindingDB50240514
ChEBI50931
CHEMBLCHEMBL908
DrugBankDB01239
DrugCentral623
KEGGcpd:C07953
dr:D00790
Therapeutic Target DatabaseD0B0CP
ZINC1137
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AbasiaOFFSIDES
2AbuseOFFSIDES
3AcneOFFSIDES
4Acute kidney injury7257872CTD
5Acute psychosisOFFSIDES
6Alanine Aminotransferase IncreasedOFFSIDES
7Alcohol consumptionOFFSIDES
8Alcohol poisoningOFFSIDES
9Anticholinergic SyndromeOFFSIDES
10AnxietyOFFSIDES
11AphoniaOFFSIDES
12Apnea7270862CTD
13Arterial InjuryOFFSIDES
14ArteriosclerosisOFFSIDES
15AspermiaOFFSIDES
16AsphyxiaOFFSIDES
17Atrioventricular BlockOFFSIDES
18Basal Ganglia Diseases6016862CTD
19Bile Duct Diseases11669021CTD
20Blood creatine phosphokinase increasedOFFSIDES
21Blood lactate dehydrogenase increasedOFFSIDES
22Bowel movement irregularityOFFSIDES
23Bulbar palsyOFFSIDES
24Chemotherapeutic drug level increasedOFFSIDES
25Cholestasis11669021CTD
26Congenital HydrocephalusOFFSIDES
27Congenital neurological disorderOFFSIDES
28Congenital scoliosisOFFSIDES
29DemyelinationOFFSIDES
30Diaphragmatic HerniaOFFSIDES
31DrowsinessOFFSIDES
32Drug addictOFFSIDES
33Drug exposure before pregnancyOFFSIDES
34Drug level below therapeuticOFFSIDES
35Dysthymic DisorderOFFSIDES
36Ear discomfortOFFSIDES
37Echocardiogram abnormalOFFSIDES
38Epidural lipomatosisOFFSIDES
39EpilepsyOFFSIDES
40Erectile dysfunctionOFFSIDES
41FatigueOFFSIDES
42Fever11669021CTD
43Gamma-Glutamyltransferase IncreasedOFFSIDES
44GastroenteritisOFFSIDES
45Gastrointestinal sounds abnormalOFFSIDES
46Granulocyte count decreasedOFFSIDES
47GranulocytosisOFFSIDES
48Hallucinations4834739CTD
49Head titubationOFFSIDES
50HemothoraxOFFSIDES
51Hepatic congestionOFFSIDES
52Hypercholesterolemia11669021CTD
53Intentional misuseOFFSIDES
54Leukopenia neonatalOFFSIDES
55Lysosomal Storage Diseases28551711CTD
56Malaria, Falciparum16882315CTD
57Mental disorders16856516CTD
58Multiple drug overdoseOFFSIDES
59Multiple drug overdose intentionalOFFSIDES
60Mycoplasma Infections10773494CTD
61OverdoseOFFSIDES
62Paranoid Personality DisorderOFFSIDES
63ParaparesisOFFSIDES
64Personality ChangeOFFSIDES
65Pregnancy Complications11669021CTD
66Pruritus11669021CTD
67Psychotic Disorders16882315
19708200
CTD
68Pustular psoriasisOFFSIDES
69Retinal pigmentationOFFSIDES
70Schizophrenia1830565CTD
OFFSIDES
71Seminal vesicular disorderOFFSIDES
72Sick Sinus SyndromeOFFSIDES
73Somnambulism453369CTD
74SoporOFFSIDES
75Stevens-Johnson SyndromeOFFSIDES
76Sudden Cardiac DeathOFFSIDES
77Sudden deathOFFSIDES
78Supraventricular tachycardiaOFFSIDES
79Syncope7257872CTD
80Tardive DyskinesiaOFFSIDES
81Teeth brittleOFFSIDES
82Tooth LossOFFSIDES
83Transaminases increasedOFFSIDES
84Ventricular FibrillationOFFSIDES
85Ventricular hypoplasiaOFFSIDES
86YawningOFFSIDES
87jaundice11669021CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.